Ghrelin inhibits ovarian epithelial carcinoma cell proliferation in vitro

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2063-2070

  Xu, Yang ^a   Pang, Xiaoyan ^a   Dong, Mei ^a   Wen, Fang ^a   Zhang, Yi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Ghrelin; Mammalian target of rapamycin; Ovarian epithelial carcinoma; Proliferation

Indexed keywords

GHRELIN; GHRELIN NEUTRALIZING ANTIBODY; GHRELIN RECEPTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; MAMMALIAN TARGET OF RAPAMYCIN; NEUTRALIZING ANTIBODY; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FROZEN SECTION; G1 PHASE CELL CYCLE CHECKPOINT; HORMONE ACTION; HORMONE INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GHRELIN; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84885033980     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2692     Document Type: Article

References (36)

1. Billottet C, Janji B, Thiery JP and Jouanneau J: Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Oncogene 21: 8128-8139, 2002.
2. Di Blasio AM, Cremonesi L, Viganó P, et al: Basic fibroblast growth factor and its receptor messenger ribonucleic acids are expressed in human ovarian epithelial neoplasms. Am J Obstet Gynecol 169: 1517-1523, 1993.
3. Chopin L, Walpole C, Seim I, et al: Ghrelin and cancer. Mol Cell Endocrinol 340: 65-69, 2011.
4. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
5. Kojima M and Kangawa K: Ghrelin: structure and function. Physiol Rev 85: 495-522, 2005.
6. Smith RG, Leonard R, Bailey AR, et al: Growth hormone secretagogue receptor family members and ligands. Endocrine 14: 9-14, 2001.
7. Majchrzak K, Szyszko K, Pawlowski KM, Motyl T and Król M: A role of ghrelin in cancerogenesis. Pol J Vet Sci 15: 189-197, 2012.
8. Zhang W, Lin TR, Hu Y, et al: Ghrelin stimulates neurogenesis in the dorsal motor nucleus of the vagus. J Physiol 559: 729-737, 2004.
9. Kim SW, Her SJ, Park SJ, et al: Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 37: 359-369, 2005.
10. De Vriese C and Delporte C: Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells. J Endocrinol 192: 199-205, 2007.
11. Waseem T, Javaid-Ur-Rehman, Ahmad F, Azam M and Qureshi MA: Role of ghrelin axis in colorectal cancer: a novel association. Peptides 29: 1369-1376, 2008.
12. Ghè C, Cassoni P, Catapano F, et al: The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 143: 484-491, 2002.
13. Gnanapavan S, Kola B, Bustin SA, et al: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87: 2988, 2002.
14. Gomez-Pinillos A and Ferrari AC: mTOR signaling pathway and mTOR inhibitors in cancer therapy. Hematol Oncol Clin North Am 26: 483-505, 2012.
15. Lynch CJ: Role of leucine in the regulation of mTOR by amino acids: revelations from structure-activity studies. J Nutr 131: 861S-865S, 2001.
16. Rosenfeldt MT and Ryan KM: The multiple roles of autophagy in cancer. Carcinogenesis 32: 955-963, 2011.
17. Mah LY and Ryan KM: Autophagy and cancer. Cold Spring Harb Perspect Biol 4: a008821, 2012.
18. Gaytan F, Morales C, Barreiro ML, et al: Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors. J Clin Endocrinol Metab 90: 1798-1804, 2005.
19. Markowska A, Ziółkowska A, Jaszczyńska-Nowinka K, Madry R and Malendowicz LK: Elevated blood plasma concentrations of active ghrelin and obestatin in benign ovarian neoplasms and ovarian cancers. Eur J Gynaecol Oncol 30: 518-522, 2009.
20. Gutierrez JA, Solenberg PJ, Perkins DR, et al: Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 105: 6320-6325, 2008.
21. Yang J, Brown MS, Liang G, Grishin NV and Goldstein JL: Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132: 387-396, 2008.
22. Lim CT, Kola B, Grossman A and Korbonits M: The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr J 58: 707-710, 2011.
23. Zhang W, Chai B, Li JY, Wang H and Mulholland MW: Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 149: 4710-4716, 2008.
24. Hosoda H, Kojima M, Matsuo H and Kangawa K: Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279: 909-913, 2000.
25. Inoki K, Corradetti MN and Guan KL: Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37: 19-24, 2005.
26. Yang Q and Guan KL: Expanding mTOR signaling. Cell Res 17: 666-681, 2007.
27. Laplante M and Sabatini DM: mTOR signaling in growth control and disease. Cell 149: 274-293, 2012.
28. LoRusso PM: Mammalian target of rapamycin as a rational therapeutic target for breast cancer treatment. Oncology 84: 43-56, 2013.
29. Fuchs Y and Steller H: Programmed cell death in animal development and disease. Cell 147: 742-758, 2011.
30. Bergmann A and Steller H: Apoptosis, stem cells, and tissue regeneration. Sci Signal 3: re8, 2010.
31. Meijer AJ: Amino acids as regulators and components of nonproteinogenic pathways. J Nutr 133: 2057S-2062S, 2003.
32. Levine B and Klionsky DJ: Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463-477, 2004.
33. Crighton D, Wilkinson S, O'Prey J, et al: DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121-134, 2006.
34. Zhang H, Bosch-Marce M, Shimoda LA, et al: Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283: 10892-10903, 2008.
35. Jung CH, Ro SH, Cao J, Otto NM and Kim DH: mTOR regulation of autophagy. FEBS Lett 584: 1287-1295, 2010.
36. Chang YY, Juhász G, Goraksha-Hicks P, et al: Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochem Soc Trans 37: 232-236, 2009.